Data / Form D filings / OncoNano Medicine, Inc.
OncoNano Medicine, Inc.: Form D filing
OncoNano Medicine, Inc., a biotechnology company in Dallas, TX, filed a Form D with the SEC in 2026. The latest, on October 8, 2026, reports $10.1 million sold of a $15 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3060 Pegasus Park Drive, Dallas, TX, 75247
- Phone
- (682) 285-1411
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1735726
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8 | New notice | $15,000,000 | $10,051,615 | $4,948,385 | 14 | Sep 23 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brent Sorrells | Executive Officer | |
| Brett Giroir | Executive Officer, Director | |
| John Dyett | Director | |
| Gina Jones | Director | |
| Yumin Qui | Director |
Other biotechnology companies in Texas that filed recently
- Solaris Endovascular Inc. $5 million · Oct 1
Every Form D from the week of Oct 5 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OncoNano Medicine, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.